// App-Quantinova.ai

: Long Follow-up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma (RATHL) Trial (CRUK/07/033) Confirms the Safety of Both De-Escalation and Intensification of Chemotherapy

Researchers

Presenter

  • Stefano Luminari

Principal Investigators

  • Alexander Fossa

  • Judith Trotman

  • Daniel Molin

  • Francesco Annibale d'Amore

  • Gunilla Enblad

  • Leanne Berkahn

  • Sally F Barrington

  • John Radford

  • Massimo Federico

  • Amy A. Kirkwood

  • Peter Johnson

Medical Centers

  • Dept of Oncology, Akademiska University Hospital, Uppsala, Sweden

  • School of Biomedical Engineering and Imaging Sciences, King's College London and Guys' & St Thomas PET Imaging Centre, London, United Kingdom

  • Department of Immunology, Genetics, and Pathology, Clinical and Experimental Oncology, Uppsala University, Uppsala Akademiska Hospital, Uppsala, Sweden

  • CHIMOMO department, Università degli Studi di Modena e Reggio Emilia, Modena, Italy

  • Hematology IRCCS Reggio Emilia, Reggio Emilia, Italy

  • Department of Haematology, Auckland City Hospital, Auckland, New Zealand

  • School of Cancer Sciences, University of Southampton, Southampton, United Kingdom

  • Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom

  • University of Manchester, Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom

  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

  • Department of Oncology, Oslo University Hospital, Oslo, Norway

  • Department of Haematology, Concord Hospital, Concord, Australia

Locations

  • Sweden

  • Italy

  • United Kingdom

  • Denmark

  • Norway

  • New Zealand

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Bleomycin

Outcome

  • N/A

Study Design

  • Randomized

  • Safety

  • Non Inferiority

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved